| # | Drug | Count |
|---|---|---|
| 0 | ADALIMUMAB | 106 |
| 1 | VEDOLIZUMAB | 48 |
| 2 | INFLIXIMAB | 38 |
| 3 | AZATHIOPRINE | 33 |
| 4 | PREDNISONE | 32 |
| 5 | METHOTREXATE SODIUM | 24 |
| 6 | PREDNISOLONE | 24 |
| 7 | PREDNISOLONE ORAL | 24 |
| 8 | PREDNISOLONE ORAL SOLUTION | 24 |
| 9 | METHOTREXATE | 22 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE | 1 | 0.0055 |
| 1 | SEVELAMER HYDROCHLORIDE | 2 | 0.0035 |
| 2 | CEFIXIME | 8 | 0.0026 |
| 3 | ESCHERICHIA COLI | 1 | 0.0025 |
| 4 | TRANDOLAPRIL TABLETS | 5 | 0.0025 |
| 5 | INFLIXIMAB-DYYB | 8 | 0.0023 |
| 6 | COLESEVELAM HYDROCHLORIDE | 2 | 0.0019 |
| 7 | CLINDAMYCIN PHOSPHATE | 8 | 0.0014 |
| 8 | CLINDAMYCIN PHOSPHATE TOPICAL | 5 | 0.0014 |
| 9 | CEFTOLOZANE AND TAZOBACTAM | 1 | 0.0010 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 73 |
| 1 | Tumor Necrosis Factor Blocker [EPC] | 62 |
| 2 | Integrin Receptor Antagonist [EPC] | 48 |
| 3 | Nonsteroidal Anti-inflammatory Drug [EPC] | 44 |
| 4 | Purine Antimetabolite [EPC] | 33 |
| 5 | Interleukin-23 Antagonist [EPC] | 23 |
| 6 | Aminosalicylate [EPC] | 22 |
| 7 | Folate Analog Metabolic Inhibitor [EPC] | 22 |
| 8 | Opioid Agonist [EPC] | 19 |
| 9 | Proton Pump Inhibitor [EPC] | 19 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Macrolide Antibacterial [EPC] | 1 | 0.0010 |
| 1 | Integrin Receptor Antagonist [EPC] | 48 | 0.0006 |
| 2 | Antimetabolite Immunosuppressant [EPC] | 9 | 0.0004 |
| 3 | Anthelmintic [EPC] | 1 | 0.0003 |
| 4 | Sigma-1 Agonist [EPC] | 3 | 0.0003 |
| 5 | CD38-directed Cytolytic Antibody [EPC] | 2 | 0.0003 |
| 6 | mu-Opioid Receptor Agonist [EPC] | 1 | 0.0003 |
| 7 | Purine Antimetabolite [EPC] | 33 | 0.0003 |
| 8 | Bile Acid Sequestrant [EPC] | 4 | 0.0003 |
| 9 | Provitamin D2 Compound [EPC] | 9 | 0.0003 |